about
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathwa...
Read More
9.57
0.43
(4.70%)
1.8M
XNAS Volume
XNAS 03 Oct, 2025 5:30 PM (EDT)
Medium Financial Strength
Expensive Valuation
Technically Moderately Bullish
Expensive Rocket
These stocks are a favourite among investors due to their bullish nature, good technical aspects but they have bad valuation and medium financials.
View Similar
Embed DVM
Kura Oncology Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..